Use of propranolol to treat multicentric airway haemangioma

Journal of Laryngology and Otology

Volumn 124, Issue 12, 2010, Pages 1329-1332

  Mistry, N ^a   Tzifa, K ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Infantile Haemangioma; Propranolol; Subglottic Haemangioma

Indexed keywords

DEXAMETHASONE; GLUCOSE; PROPRANOLOL;

ARTICLE; BLOOD PRESSURE MONITORING; BREATHING DISORDER; BRONCHOSCOPY; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMANGIOMA; HUMAN; HYPOPHARYNX; INFANT; LARYNX HEMANGIOMA; LARYNX TUMOR; NEBULIZER; PHARYNX; PHARYNX HEMANGIOMA; PHARYNX TUMOR; STRIDOR; UPPER RESPIRATORY TRACT OBSTRUCTION;

ADRENERGIC BETA-ANTAGONISTS; AIRWAY OBSTRUCTION; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; ENDOSCOPY; FEMALE; HEMANGIOMA; HUMANS; INFANT; LARYNGEAL NEOPLASMS; PROPRANOLOL;

EID: 78649959107     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S002221511000068X     Document Type: Article

References (16)

1. O-Lee TJ, Messner A. Subglottic haemangioma. Otolaryngol Clin North Am 2008;41:903-11
2. Saetti R, Silvestrini M, Cutrone C, Narne S. Treatment of congenital subglottic haemangiomas. Arch Otolaryngol Head Neck Surg 2008;134:848-51
3. Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic hemangioma. J Otolaryngol 2000;29:361-6
4. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Thambo JB, Taïeb A. Propranolol for severe haemangiomas of infancy. N Engl J Med 2008;358:2649-51
5. Rahbar R, Nicollas R, Roger G, Triglia J-M, Garabedian EN, McGill TJ et al. The biology and management of subglottic haemangioma: Past, present and future. Laryngoscope 2004;114:1880-91
6. Bailey CM, Froehlich P, Hoeve HL. Management of subglottic haemangioma. J Laryngol Otol 1998;112:765-8
7. Bitar MA,MourkarbelRV, Zalzal GH. Management of congenital subglottic hemangioma: Trends and success over the past 17 years. Otolaryngol Head Neck Surg 2005;132:226-31
8. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004;140:963-9
9. Suehs OW, Herbur PA. Hemangiomas of the larynx in infants. Arch Otolaryngol 1940;32:783-9
10. Healy G, McGill T, Friedman EM. Carbon dioxide laser in subglottic hemangioma. An update. Ann Otol Rhinol Laryngol 1984;93:370-3
11. Brodsky L, Yoshpe N, Ruben RJ. Clinical-pathological correlates of congenital subglottic hemangiomas. Ann Otol Rhinol Laryngol 1983;105:4-18
12. Chatrath P, Black M, Jani P, Albert DM, Bailey CM. A review of the current management of infantile subglottic haemangioma, including a comparison of CO2 laser therapy versus tracheostomy. Int J Pediatr Otorhinolaryngol 2002;64:143-57
13. Sharp HS. Haemangioma of the trachea in an infant; successful removal. J Laryngol Otol 1949;63:413
14. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-72
15. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope 2009;119:2051-4
16. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359: 2846-7